Skip to main navigation
TCR² Therapeutics
  • Our Science
  • Our Pipeline
  • Patients
  • About Us
  • Investors & Media
    • Overview
    • Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • Analyst Coverage
    • Events
    • SEC Filings
    • FAQs
  • Get in Touch
  • Join Us
  • Home
  • Our Science
  • Our Pipeline
  • Patients
  • About Us
  • Investors & Media
    ►
      ◄ Back
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • FAQs
  • Get in Touch
  • Join Us

Investors & Media

Press Releases

All News | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |

Dec 19, 2018

TCR² Therapeutics Announces Oncology Industry Leader and Expert Andrew Allen, M.D., Ph.D. Joins its Board of Directors

Nov 29, 2018

TCR² Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards™ Life Sciences 2018 Event

May 14, 2018

TCR² Therapeutics to Present at the UBS Global Healthcare Conference and the Jefferies 2018 Global Healthcare Conference

Apr 12, 2018

TCR² Therapeutics to Present New Preclinical Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting

Apr 10, 2018

TCR² Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer

Mar 21, 2018

TCR² Therapeutics Raises $125 Million in Oversubscribed Series B Financing

Mar 06, 2018

TCR² Therapeutics to Present at the Cowen and Company 38th Annual Healthcare Conference and Needham & Company 17th Annual Healthcare Conference

Feb 05, 2018

TCR² Therapeutics to Present at the 2018 Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond

Jan 03, 2018

TCR² Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
  • Our Science
  • Our Pipeline
  • Patients
  • About Us
  • Investors & Media
  • Get in Touch
  • Join Us

© 2022 TCR² Therapeutics. All rights reserved.

TCR² Therapeutics